Physician profile
Timmothy Reece
NPI 1679794762
$1,245.02
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $253 · 2021: $226 · 2022: $92.23 · 2023: $114 · 2024: $20.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $219.91 | 2019-2022 | |
| Pfizer INC. | $117.77 | 2019-2023 | |
| Amgen INC. | $78.49 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $71.76 | 2019-2021 | |
| Novo Nordisk INC | $67.55 | 2019-2020 | |
| Abbvie INC. | $64.52 | 2021 | |
| Allergan, INC. | $64.13 | 2019 | |
| Amarin Pharma, INC. | $59.82 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.59 | 2019-2023 | Trintellix |
| Sanofi-Aventis U.S. LLC | $46.26 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $46.18 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.19 | 2019-2021 | |
| Sanofi Pasteur INC. | $42.69 | 2020-2023 | |
| Redhill Biopharma INC. | $42.52 | 2020-2021 | |
| Abbott Laboratories | $39.41 | 2023 | Freestyle Libre 3 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $35.88 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $30.87 | 2019 | |
| Glaxosmithkline, LLC. | $28.47 | 2020-2022 | |
| Fujifilm Healthcare Americas Corporation | $20.07 | 2023 | Magnification Table |
| Seqirus USA INC | $20.01 | 2024 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $15.90 | 2019 | |
| Ardelyx, INC. | $15.67 | 2022 | |
| Currax Pharmaceuticals LLC | $15.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timmothy Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.